Original Source(s)
Related Content
FDA approves tau PET imaging agent
The F18-labeled agent is indicated for brain PET imaging to identify tau neurofibrillary tangle pathology.
August 14, 2026
-
2 min
AI cuts lesion measurement time by 34%
Automated lesion measurements increased agreement on treatment response, although expert-generated proposals were accepted more often and required fewer adjustments.
September 3, 2026
-
4 min
FDA guidance spurs adoption of change control plans for radiology AI devices
Investigators examined adoption and public documentation of change control plans for FDA-cleared radiology AI devices.
September 16, 2026
-
3 min